Key facts
- This page summarizes Thomas Appio's Form 4 filing for Bausch Health Companies Inc. (BHC).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Sep 2022, 16:35.
Thomas Appio - 01 Sep 2022 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- BHC
- Reported as of
- 01 Sep 2022
- Net transaction value
- -$101,414
- SEC form
- 4
- Accepted by SEC
- 02 Sep 2022, 16:35:53 UTC
- Prior SEC filing
- 12 May 2022
- Next SEC filing
- 01 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Brianna M. Cetrulo, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Thomas Appio filed Form 4 for Bausch Health Companies Inc. (BHC) on 02 Sep 2022.
Change
- Previous filing in this sequence was filed on 12 May 2022.
- Current net transaction value: -$101,414.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BHC
transaction
Common Shares, No Par Value
Disposed to Issuer
- Transaction value
- $101,414
- Shares
- -15,389
- Change %
- -3%
- Price
- $6.59
- Shares after
- 491,900
- Date
- 01 Sep 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.